Chemical industry – Page 70
-
OpinionBe careful what you wish for
Measuring R&D productivity is a thorny issue. Dennis Lendrem urges the pharmaceutical industry to learn from its mistakes.
-
Business
Valeant heads off Endo bid for Salix
Bid raised to $15.8 billion in cash after rival offer from Irish firm
-
OpinionAnalogues by catalogue
Buying in screening compounds directly feels like cutting out the synthetic chemist middleman, says Derek Lowe
-
Business23andMe jumps into drug R&D
Gene profiling firm aims to capitalise on its databank of genetic information to discover new drugs
-
-
Business
Drug firms warned to be honest with investors
Official warns of ‘significant consequences’ if companies aren’t forthcoming about their FDA interactions
-
Business
BASF introduces bio-based polyTHF
Process uses 1,4-butanediol from microbial digestion of sugar feedstocks to make component of polyester and polyurethane materials
-
Business
Amgen to axe 300 Onyx employees
Amgen will close its Onyx facility in South San Francisco in December
-
Business
Mergers and moves trigger pharma layoffs
Shire expects to sack 500 or more employees, while Merck and GSK also wield the axe
-
Business
US approves biosimilar filgrastim
Sandoz’s version of Amgen’s Neupogen is ‘biosimilar’ but not ‘interchangeable’
-
BusinessAbbVie to buy Pharmacyclics for pipeline boost
$21bn deal gives AbbVie a share in sales of blockbuster cancer drug as its own biggest sellers face patent expiry
-
Business
Mallinckrodt to buy Ikaria to expand in US hospitals
$2.3bn deal brings nitric oxide ventilator system for newborns with respiratory failure
-
Business
J&J to sell cardiac devices to wholesaler Cardinal
Commodity technology no longer fits with company’s focus on growth and innovation
-
Business
AstraZeneca to spin off anti-infectives research
Early-stage research will transfer to a new company, while AZ and MedImmune retain late-stage programmes
-
FeatureThe enzyme hunters
Novozymes is scouring the world for enzymes that make industrial processes more sustainable, as Mark Peplow discovers
-
Business
Asahi Kasei to buy Polypore for battery materials
$2.2bn deal adds to Japanese consolidation in energy storage
-
BusinessUS opens up home DNA screening
FDA approves single disease genetic test and clears pathway for similar devices
-
BusinessCatalytic carbon dioxide convertors
Company profile: Econic Technologies makes catalysts that build carbon dioxide into performance polymers
-
Business
BMS bolsters immuno-oncology with pair of deals
Firm will acquire Flexus Biosciences and collaborate with Rigel